• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区获得性艰难梭菌感染的结局。

Outcomes in community-acquired Clostridium difficile infection.

机构信息

Division of Gastroenterology, Mayo Clinic, Rochester, MN, USA.

出版信息

Aliment Pharmacol Ther. 2012 Mar;35(5):613-8. doi: 10.1111/j.1365-2036.2011.04984.x. Epub 2012 Jan 10.

DOI:10.1111/j.1365-2036.2011.04984.x
PMID:22229532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3293482/
Abstract

BACKGROUND

Community-acquired Clostridium difficile infection (CA-CDI) is an increasingly appreciated condition. It is being described in populations lacking traditional predisposing factors that have been previously considered at low-risk for this infection. As most studies of CDI are hospital-based, outcomes in these patients are not well known.

AIM

To examine outcomes and their predictors in patients with CA-CDI.

METHODS

A sub-group analysis of a population-based epidemiological study of CDI in Olmsted county, Minnesota from 1991-2005 was performed. Data regarding outcomes, including severity, treatment response, need for hospitalisation and recurrence were analysed.

RESULTS

Of 157 CA-CDI cases, the median age was 50 years and 75.3% were female. Among all CA-CDI cases, 40% required hospitalisation, 20% had severe and 4.4% had severe-complicated infection, 20% had treatment failure and 28% had recurrent CDI. Patients who required hospitalisation were significantly older (64 years vs. 44 years, P < 0.001), more likely to have severe disease (33.3% vs. 11.7%, P = 0.001), and had higher mean Charlson comorbidity index scores (2.06 vs. 0.84, P = 0.001). They had similar treatment failure and recurrence rates as patients who did not require hospitalisation.

CONCLUSIONS

Community-acquired Clostridium difficile infection can be associated with complications and poor outcomes, including hospitalisation and severe Clostridium difficile infection. As the incidence of community-acquired Clostridium difficile infection increases, clinicians should be aware of risk factors (increasing age, comorbid conditions and disease severity) that predict the need for hospitalisation and complications in patients with community-acquired Clostridium difficile infection.

摘要

背景

社区获得性艰难梭菌感染(CA-CDI)是一种日益受到关注的疾病。它正在被描述为缺乏先前被认为感染风险较低的传统易感因素的人群中发生。由于大多数 CDI 研究都是基于医院的,因此这些患者的结局尚不清楚。

目的

研究 CA-CDI 患者的结局及其预测因素。

方法

对明尼苏达州奥姆斯特德县 1991-2005 年一项基于人群的 CDI 流行病学研究进行亚组分析。分析了结局相关数据,包括严重程度、治疗反应、住院需求和复发情况。

结果

在 157 例 CA-CDI 病例中,中位年龄为 50 岁,75.3%为女性。在所有 CA-CDI 病例中,40%需要住院,20%患有严重疾病,4.4%患有严重合并感染,20%治疗失败,28%复发 CDI。需要住院的患者年龄明显较大(64 岁 vs. 44 岁,P < 0.001),更有可能患有严重疾病(33.3% vs. 11.7%,P = 0.001),且 Charlson 合并症指数评分更高(2.06 vs. 0.84,P = 0.001)。他们的治疗失败和复发率与不需要住院的患者相似。

结论

社区获得性艰难梭菌感染可导致并发症和不良结局,包括住院和严重艰难梭菌感染。随着社区获得性艰难梭菌感染的发病率增加,临床医生应了解预测患者需要住院和并发症的危险因素(年龄增加、合并症和疾病严重程度)。

相似文献

1
Outcomes in community-acquired Clostridium difficile infection.社区获得性艰难梭菌感染的结局。
Aliment Pharmacol Ther. 2012 Mar;35(5):613-8. doi: 10.1111/j.1365-2036.2011.04984.x. Epub 2012 Jan 10.
2
The epidemiology of Clostridium difficile infection in children: a population-based study.儿童艰难梭菌感染的流行病学:一项基于人群的研究。
Clin Infect Dis. 2013 May;56(10):1401-6. doi: 10.1093/cid/cit075. Epub 2013 Feb 13.
3
Community-associated Clostridium difficile infection: how real is it?社区获得性艰难梭菌感染:它有多真实?
Anaerobe. 2013 Dec;24:121-3. doi: 10.1016/j.anaerobe.2013.01.006. Epub 2013 Feb 8.
4
Clostridium difficile infection in children hospitalized due to diarrhea.儿童因腹泻住院时的艰难梭菌感染。
Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):201-9. doi: 10.1007/s10096-013-1946-1. Epub 2013 Nov 10.
5
The epidemiology of community-acquired Clostridium difficile infection: a population-based study.社区获得性艰难梭菌感染的流行病学:一项基于人群的研究。
Am J Gastroenterol. 2012 Jan;107(1):89-95. doi: 10.1038/ajg.2011.398. Epub 2011 Nov 22.
6
Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren.塞尔维亚儿童中复发性社区获得性艰难梭菌(艰难梭菌)感染。
Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):509-516. doi: 10.1007/s10096-019-03751-4. Epub 2019 Nov 12.
7
A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes.科威特社区相关性艰难梭菌感染的前瞻性研究:流行病学与核糖型
Anaerobe. 2015 Oct;35(Pt B):28-32. doi: 10.1016/j.anaerobe.2015.06.006. Epub 2015 Jul 2.
8
A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.一项社区相关性艰难梭菌感染的前瞻性研究:抗生素和合并感染的作用。
J Infect. 2014 Aug;69(2):134-44. doi: 10.1016/j.jinf.2014.04.002. Epub 2014 Apr 26.
9
Clinical factors associated with development of severe-complicated Clostridium difficile infection.与严重复杂性艰难梭菌感染发展相关的临床因素。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1466-71. doi: 10.1016/j.cgh.2013.04.050. Epub 2013 May 20.
10
Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England.评估行政数据评估英格兰艰难梭菌感染获得性转移。
J Hosp Infect. 2012 Mar;80(3):229-37. doi: 10.1016/j.jhin.2012.01.001. Epub 2012 Feb 4.

引用本文的文献

1
Epidemiologic profile of community-acquired infections: a systematic review and meta-analysis.社区获得性感染的流行病学概况:一项系统评价和荟萃分析。
Epidemiol Infect. 2025 Mar 4;153:e46. doi: 10.1017/S0950268825000202.
2
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.一种用于复发性艰难梭菌感染的微生物组疗法3期试验的综合安全性和有效性分析。
Infect Dis Ther. 2024 Oct;13(10):2105-2121. doi: 10.1007/s40121-024-01007-z. Epub 2024 Jun 28.
3
Community-Acquired Severe Clostridium difficile Enteritis Complicated by Metabolic Acidosis and Acute Kidney Injury.社区获得性严重艰难梭菌肠炎并发代谢性酸中毒和急性肾损伤
Cureus. 2023 Jul 13;15(7):e41804. doi: 10.7759/cureus.41804. eCollection 2023 Jul.
4
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.ECOSPOR III 研究中复发性艰难梭菌感染患者合并症的流行情况,这是一项口服微生物组为基础的治疗的随机试验。
Clin Infect Dis. 2023 Nov 30;77(11):1504-1510. doi: 10.1093/cid/ciad448.
5
Rapid visualization of toxins A and B by multiplex RPA combined with CRISPR-Cas12a.通过多重重组酶聚合酶扩增(RPA)结合CRISPR-Cas12a快速检测毒素A和B
Front Microbiol. 2023 Mar 8;14:1119395. doi: 10.3389/fmicb.2023.1119395. eCollection 2023.
6
Retrospective Cohort Analysis of Outpatient Antibiotic Use for -Indicated Agents in British Columbia, from 2000 to 2018.2000年至2018年不列颠哥伦比亚省门诊抗生素用于特定药物的回顾性队列分析。
Can J Infect Dis Med Microbiol. 2023 Feb 10;2023:9465158. doi: 10.1155/2023/9465158. eCollection 2023.
7
Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020.加拿大 2015-2020 年原发性和复发性与医疗保健相关及社区相关儿童艰难梭菌感染的流行病学。
J Pediatric Infect Dis Soc. 2023 Apr 28;12(4):222-225. doi: 10.1093/jpids/piad003.
8
Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection.缺血性结肠炎是艰难梭菌感染的一个危险因素。
Cureus. 2022 Jun 19;14(6):e26076. doi: 10.7759/cureus.26076. eCollection 2022 Jun.
9
Rifaximin Therapy for Patients With Metronidazole-Unresponsive Clostridium difficile Infection.利福昔明治疗甲硝唑无反应性艰难梭菌感染患者
Cureus. 2022 Apr 14;14(4):e24140. doi: 10.7759/cureus.24140. eCollection 2022 Apr.
10
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.加拿大 2015-2019 年成人相关医疗保健和社区获得性艰难梭菌感染的特征
Emerg Infect Dis. 2022 Jun;28(6):1128-1136. doi: 10.3201/eid2806.212262. Epub 2022 Apr 26.

本文引用的文献

1
The epidemiology of community-acquired Clostridium difficile infection: a population-based study.社区获得性艰难梭菌感染的流行病学:一项基于人群的研究。
Am J Gastroenterol. 2012 Jan;107(1):89-95. doi: 10.1038/ajg.2011.398. Epub 2011 Nov 22.
2
Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.系统评价:质子泵抑制剂的使用与肠道感染易感性增加的关系。
Aliment Pharmacol Ther. 2011 Dec;34(11-12):1269-81. doi: 10.1111/j.1365-2036.2011.04874.x. Epub 2011 Oct 17.
3
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease.炎症性肠病患者中艰难梭菌相关性腹泻的健康负担增加。
Aliment Pharmacol Ther. 2011 Jun;33(12):1322-31. doi: 10.1111/j.1365-2036.2011.04661.x. Epub 2011 Apr 24.
4
Development and validation of a Clostridium difficile infection risk prediction model.开发和验证艰难梭菌感染风险预测模型。
Infect Control Hosp Epidemiol. 2011 Apr;32(4):360-6. doi: 10.1086/658944.
5
Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.利用病历链接系统对动态人群进行随时间的计数:罗切斯特流行病学项目。
Am J Epidemiol. 2011 May 1;173(9):1059-68. doi: 10.1093/aje/kwq482. Epub 2011 Mar 23.
6
A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.社区相关性艰难梭菌感染的病例对照研究:质子泵抑制剂无作用。
Am J Med. 2011 Mar;124(3):276.e1-7. doi: 10.1016/j.amjmed.2010.10.013.
7
Epidemiology of community-onset Clostridium difficile infection in a community in the South of England.英格兰南部某社区社区获得性艰难梭菌感染的流行病学。
J Infect Public Health. 2010;3(3):118-23. doi: 10.1016/j.jiph.2010.07.002. Epub 2010 Aug 23.
8
The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.艰难梭菌感染在住院和门诊环境中的发病率和严重程度不断增加。
Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):409-16. doi: 10.1586/egh.10.48.
9
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).艰难梭菌感染临床实践指南:美国医疗保健流行病学学会(SHEA)和美国传染病学会(IDSA)2010 年更新版。
Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.
10
Detection and characterization of Clostridium difficile in retail chicken.检测零售鸡肉中的艰难梭菌及其特征分析。
Lett Appl Microbiol. 2010 Apr;50(4):362-5. doi: 10.1111/j.1472-765X.2010.02802.x. Epub 2010 Jan 11.